Erythromer, a nanoscale bio-synthetic artificial red cell

VJHemOnc Video Journal of Hematological Oncology

Published on Dec 16, 2016

Press brief by Allan Doctor, MD of Washington University School of Medicine, St. Louis, MO, on erythromer (EM), a nanoscale bio-synthetic artificial red cell: proof of concept and In vivo efficacy results. Recorded at the 2016 American Society of Hematology (ASH) Annual Meeting, held in San Diego, CA

CONTACT US

info@kalocyte.com

670 West Baltimore Street
HSRF III, 8th Floor
Baltimore, Maryland 21201

QUICK LINKS

Mission
About
Erythromer
News & Events
Team
Careers
Contact

ABOUT US

KaloCyte was founded by a distinguished team of researchers in physiology, bioengineering, and trauma care and is poised to deliver ErythroMer, a dried, bio-inspired artificial red blood cell, to market. ErythroMer is envisioned for use when stored red blood cells are unavailable, undesirable or in short supply. KaloCyte is supported by nearly $20M in federal grants and investor funding.